NUMIF - Psychedelic Stocks = Super-Risky Biotechs Low On Cash. Make Small Bets.
2023-07-16 18:00:00 ET
Summary
- Alex Carchidi returns to update investors on the psychedelics industry.
- Collapse, consolidation, and why you shouldn't bet on just 1 stock.
- Compass Pathways' timeline for clinical trials; Atai and Cybin's recent wins.
For further details see:
Psychedelic Stocks = Super-Risky Biotechs Low On Cash. Make Small Bets.